Mindray Launches High-Sensitivity and High-Specificity ToRCH Panel
By LabMedica International staff writers Posted on 28 Sep 2022 |
Mindray (Shenzhen, China) has launched the ToRCH Panel that provides high-quality assays to meet different clinical needs. Thanks to the improved raw materials, processes, formulas, reaction models, and standardized traceability, Mindray ToRCH reagents deliver excellent seroconversion sensitivity. Mindray ToRCH has a good detection rate for both samples that are positive in multiple systems and true positive samples such as seroconversion panels. Mindray ToRCH kits support diverse sample types with less quality controls and sample volumes, which ensures great ease and convenience during clinical detection. By bringing the clinical benefits of ToRCH Panel into play and addressing the key requirements for the reagents, Mindray has solved the ToRCH detection challenges facing clinical laboratories and made Mindray ToRCH assays accessible in clinical application.
To achieve high sensitivity and specificity, Mindray has been working consistently to improve the raw materials, processes, formulas, and reaction models. High quality materials are fundamental to ensure high sensitivity and specificity of CLIA assays. To cater to different projects and process requirements, Mindray invested significant resources in the design and development of immunodominant proteins and immunodominant epitopes. Mature, stable and innovative technology is another guarantee of satisfactory performance. For the coating and labeling processes, the Mindray R&D team selected the particles and ALPs that can best meet the assay requirements. To improve the sensitivity and specificity, the Mindray experts spent a considerable amount of time thoroughly studying the parameters using a DOE approach. With a robust design, the boundary of each parameter was determined to ensure the reproducibility of the process.
At the formulation level, the Mindray R&D experts investigated the interference mechanism and classified the interference into four different types to help enhance the anti-interference capacity. Hundreds of commercial and uniquely designed blockers were studied and applied to minimize each type of interference. For instance, the Mindray R&D team designed a capture method for the IgM assay to minimize the interference of IgG and RF (Rheumatoid Factor). The Toxo IgG, CMV IgG and RV IgG quantitative kits of the Mindray ToRCH panel are fabricated with materials with international standard units and the latest standardized traceability. Toxo IgG contains specific IgG and features DT test standardization. CMV IgG adopts the first international standard and features long-term stability. RV IgG comes with a cutoff value of 10 IU/mL as recommended by WHO. The combined examination by Mindray ToRCH IgG and IgM can accurately reveal previous infections and promptly detect ToRCH infections that failed to be ruled out previously.
To demonstrate the sensitivity and specificity of the Mindray ToRCH kits, Mindray conducted tests in over five clinical sites both in and outside China. Although the positive rate varies among different countries and regions, Mindray ToRCH kits have exhibited great specificity for Toxo IgG and ToRCH IgM and excellent sensitivity for RV IgG and CMV IgG. In addition, given the wide coverage of the clinical tests, there are no significant differences between the Chinese and international sites.
Related Links:
Mindray
Latest Molecular Diagnostics News
- Novel Method Combining Nano Informatics and AI Paves Way for Cancer Blood Tests
- Groundbreaking Molecular Diagnostic Kit to Provide Lyme Disease Detection in Minutes
- New Assay Detects Heart Failure Biomarker in Less than 11 Minutes
- Innovative Test Improves Assessment of Patients with Mild Traumatic Brain Injury
- New Method for Lung Microbiomes Analysis Predicts Mortality in Children after Bone Marrow Transplant
- Novel Technique Detects Biomarkers for Kidney Diseases with Nephritic Syndrome
- Lipoprotein Blood Test Detects Hereditary Cardiovascular Risk
- Whole Genome Sequencing Detects Infection Transmission in NICU
- Novel Inexpensive, Shelf-Stable, Easy To Use Tests Bring Lab-Level Precision at POC
- World’s First One-Minute Hepatitis C Antibody Test Facilitates Quick Triage
- Game-Changing Blood Test for Stroke Detection Could Bring Life-Saving Care to Patients
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections